Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,925 | -23,574 | -153,494 | -127,130 | -93,783 |
| Depreciation Amortization | 153 | 101 | -1,568 | -1,568 | 152 |
| Accounts receivable | -55,675 | -22,330 | -12,780 | 599 | 653 |
| Other Working Capital | -54,653 | -30,080 | -27,914 | -10,850 | 2,654 |
| Other Operating Activity | 69,778 | 30,567 | 33,312 | 14,830 | 8,475 |
| Operating Cash Flow | $-78,322 | $-45,316 | $-162,444 | $-124,119 | $-81,849 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,901 | -20,634 | 61,847 | 34,113 | 2,628 |
| PPE Investments | -114 | -54 | -289 | -272 | -185 |
| Investing Cash Flow | $-19,015 | $-20,688 | $61,558 | $33,841 | $2,443 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 65,346 | 65,346 | N/A | N/A | N/A |
| Common Stock Issued | 1,066 | 179 | 41,773 | 7,973 | 330 |
| Other Financing Activity | -708 | -321 | -1,855 | 629 | 0 |
| Financing Cash Flow | $65,704 | $65,204 | $39,918 | $8,602 | $330 |
| Beginning Cash Position | 112,095 | 112,095 | 173,063 | 173,062 | 173,062 |
| End Cash Position | 80,462 | 111,295 | 112,095 | 91,386 | 93,986 |
| Net Cash Flow | $-31,633 | $-800 | $-60,968 | $-81,676 | $-79,076 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,322 | -45,316 | -162,444 | -124,119 | -81,849 |
| Capital Expenditure | -114 | -54 | -289 | -272 | -185 |
| Free Cash Flow | -78,436 | -45,370 | -162,733 | -124,391 | -82,034 |